BIN YI, Ph.D.
Pharmaceutical and Biomedical Sciences
Associate Research Scientist
Pharmaceutical and Biomedical Sciences
Pharmaceutical and Biomedical Sciences
Education
Ph.D.-Kunming Institute of Zoology Chinese Academy of Sciences, 2012
Master of Science-Kunming Institute of Zoology Chinese Academy of Sciences, 2009
Bachelor of Engineering-Huaihua University, 2006
More About
Dr. Bin Yi is an Associate Research Scientist at the University of Georgia’s College of Pharmacy, Department of Pharmaceutical and Biomedical Sciences. Currently, he serves as a Graduate Program Faculty member at the University of Georgia, contributing to the academic and professional development of students in the pharmaceutical sciences.
Honors, Awards, and Achievements
Scholarship of Hunan Province Excellent Student, 2004
Excellent Student and Outstanding Student Leader Award of Graduate University of Chinese Academy of Sciences, 2008
Excellent Student of Graduate University of Chinese Academy of Sciences, 2010
Award for CST Excellent Young Poster of Chinese Society for Cell Biology, 2011
The Second Award from Academic Report of Annual Symposium of Key Laboratory of Animal Models and Human Disease Mechanism of Chinese Academy of Sciences and Yunnan, 2011
American Society of Clinical Oncology, awarded for Travel Grant for Best of ASCO Meeting in Chicago, 2013
Research Incentive Award ($6,678), 2022
Course Instruction
In addition to his research, Dr. Yi is dedicated to teaching and mentoring students at various academic levels, guiding them through research projects and scientific presentations. He also plays a vital role in departmental service, participating in numerous committees and review panels. Dr. Yi’s commitment to advancing cancer research and education makes him a valuable asset to the scientific community.
Research Interests
Dr. Yi’s research focuses on three main areas: 1. Developing novel therapeutic strategies for colon and breast cancer, both in vitro and in vivo. 2. Identifying and characterizing novel molecules in the tumor microenvironment that influence cancer progression. 3. Studying exosomal miRNAs and their role in cancer metastasis.
